Figure 1.
IL17-secreting cells are increased in murine and human pancreatic adenocarcinoma carcinoma. (A) Heat map representing serum levels of cytokines from a spontaneous pancreatic adenocarcinoma mouse model (KPC) and control mice (Pdx1-Cre) at 1 mo and 6 mo of age. (B) Serum IL17 levels measured by Luminex assay in Pdx-Cre and KPC mice at 1 mo and 6 mo of age. Results show the mean ± SD of fold changes from KPC over Pdx-Cre (n = 5). (C) Relative IL17 mRNA expression measured by quantitative RT-PCR in normal pancreatic tissue and tumor tissue formed from KPC cells orthotopically implanted into syngeneic mice. Results show the mean ± SD of fold changes from KPC tumors over normal pancreas (n = 5). (D) Th17 cells in normal human pancreatic tissue and PDAC based on RORγt staining by IHC. Scale bars represent 50 µm. (E) Quantification of human RORγt+ cells on tissue from normal versus PDAC. (F) Kaplan-Meier survival curves comparing survival of patients with PDAC with low versus high levels of median IL17A expression. *, P < 0.05; ***, P < 0.001; ****, P < 0.0001.